ReviewFrontiers in immunology2025

PKM2 orchestrates tumor progression via metabolic reprogramming and MDSCs-mediated immune suppression in the tumor microenvironment.

Wenxi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.